Loading...
High cumulative doxorubicin dose for advanced soft tissue sarcoma
BACKGROUND: The recommended cumulative doxorubicin dose in soft tissue sarcoma (STS) treatment was based on cardiotoxicity data from retrospective studies of breast cancer patients. However, the treatment and prognosis of STS and breast cancer are quite different, and reference to breast cancer data...
Na minha lista:
| Udgivet i: | BMC Cancer |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7684756/ https://ncbi.nlm.nih.gov/pubmed/33228579 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-020-07663-x |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|